Stay updated on Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page
- Check6 days agoChange DetectedA site-wide banner announces NIH’s transition from the term “artificial intelligence” to “super intelligence” and directs visitors to transition updates and FAQs.SummaryDifference0.5%

- Check13 days agoChange DetectedThe ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check20 days agoChange DetectedThe site footer’s software revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check41 days agoChange DetectedThe record history now shows Revision: v3.7.0 replacing the previous v3.6.6, indicating a software revision of the page. This reflects an internal update to the page's rendering/versioning rather than content changes to the study information.SummaryDifference0.1%

- Check62 days agoChange DetectedThe study record history now includes a new revision tag, v3.6.6, and removes the previous v3.6.5 tag, updating the visible revision history.SummaryDifference0.1%

- Check83 days agoChange DetectedThe revision history now includes the latest revision entry, v3.6.5, and drops the previous v3.6.4. This reflects an update to the page's revision metadata rather than any user-facing content change.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.